SLN

#3386
Silence Therapeutics Plc American Depository Share
6.43 USD
+5.07%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
6.22
6.46
Intervallo Annuale
2.63
7.91
Variazione giornaliera
+5.07%
Variazione Mensile
-14.27%
Variazione di 6 mesi
-0.77%
Variazione Annuale
+125.61%
Chiusura Precedente
6.12
Apertura
6.29
Bid
Ask
Minimo
6.22
High
6.46
Volume
93
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche
Trimestrale Annuale
Conto economico Bilancio Liquidità
Valore Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25 TTM

Silence Therapeutics Plc - American Depository Share

Silence Therapeutics is a London-based pharmaceutical company formed in 1994. The company has pioneered the development of short-interfering ribonucleic acid therapeutics for the treatment of rare diseases. Silence Therapeutics has offices in London, New Jersey, and Berlin, with its corporate headquarters located in Hammersmith, London.

Notizie